The small molecule drug developer, which numbers SR One among its investors, has now secured $90m in overall capital.

The spin-out from the National University of Singapore (NUS) will make performing molecular diagnosis in the body a reality.

The North Dakota Centers of Excellence Commission has awarded funding requests for grants totaling close to $1.3m.

The fertility drug developer has now secured $20.9m after welcoming Novo to its investor base.

The healthcare system provider has now raised almost $120m from investors including Google's corporate venturing unit.

A local press report has stated that India-based Videocon could follow up an investment in pharmaceutical company Dr Datsons by acquiring the company.

Iconic, which develops treatments for eye disorders, has now raised almost $32m after securing $20m in is series B round.

The medical practice has participated in a $5m round raised by the healthcare app, and will also provide its trained professionals for the service.

Mayo Clinic has joined medical device maker Q-Med as an investor in the company, which is testing a drug that will prevent kidney failure.